Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab

Abstract The bone mass benefits of antiresorbers in postmenopausal osteoporosis are limited by the rapid coupling of decreasing bone resorption with bone formation. Wnt signaling is involved in this coupling process during treatment with bisphosphonates, whereas its role during treatment with the an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Davide Gatti, Ombretta Viapiana, Elena Fracassi, Luca Idolazzi, Carmela Dartizio, Maria Rosaria Povino, Silvano Adami, Maurizio Rossini
Formato: Artigo
Idioma:inglés
Publicado: 2012
Acceso en liña:https://doi.org/10.1002/jbmr.1681
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!